Dataset
Sulfapyridine; LC-ESI-QTOF; MS2; CE: 40 eV; R=35000; [M+H]+
Chemical Information
| InChI | InChI=1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14) |
|---|---|
| SMILES | NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1 |
| InChI Key | GECHUMIMRBOMGK-UHFFFAOYSA-N |
| Molecular Formula | C11H11N3O2S |
| Exact Mass | 249.057 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU234404 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2019-05-30 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| 5336 | PubChem |
| PD001745 | ProbesDrugs |
| Y5V2N1KE8U | FDA SRS |
| LSM-5531 | LINCS |
| SCHEMBL44219 | SureChEMBL |
| 144-83-2 | ACToR |
| Sulfapyridine(Dagenan) | Selleck |
| 15221159 | PubChem: Thomson Pharma |
| 511929 | eMolecules |
| CB8423160 | ChemicalBook |
| 12698 | Brenda |
| PA164779050 | PharmGKB |
| MCULE-7911106459 | Mcule |
| 20202461 | NMRShiftDB |
| DB00891 | DrugBank |
| CHEMBL700 | ChEMBL |
| 132842 | ChEBI |
| SULFAPYRIDINE | clinicaltrials |
| HY-B0212 | MedChemExpress |
| DTXSID3026067 | EPA CompTox Dashboard |
| ZINC000000002105 | ZINC |
| J5.831I | Nikkaji |
| BEWKUJ | CCDC |
| 39340 | BindingDB |
| SULFAPYRIDINE | rxnorm |
| SFY | PDBe |
| 2524 | DrugCentral |
| HMDB0015028 | Human Metabolome Database |
| The data in this table is sourced from UniChem at EBI. | |